EKSO BIONICS HLDGS INC's ticker is and the CUSIP is 282644301. A total of 38 filers reported holding EKSO BIONICS HLDGS INC in Q4 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,925 | -35.8% | 12,179 | +25.3% | 0.00% | – |
| Q2 2023 | $13,896 | -13.0% | 9,719 | +0.4% | 0.00% | – |
| Q1 2023 | $15,973 | +31.7% | 9,682 | -4.9% | 0.00% | – |
| Q4 2022 | $12,129 | -24.2% | 10,182 | +2.3% | 0.00% | – |
| Q3 2022 | $16,000 | 0.0% | 9,949 | +0.5% | 0.00% | – |
| Q2 2022 | $16,000 | -42.9% | 9,895 | 0.0% | 0.00% | – |
| Q1 2022 | $28,000 | +7.7% | 9,895 | +0.1% | 0.00% | – |
| Q4 2021 | $26,000 | -10.3% | 9,882 | +59.4% | 0.00% | – |
| Q3 2021 | $29,000 | -17.1% | 6,201 | -3.1% | 0.00% | – |
| Q2 2021 | $35,000 | +1650.0% | 6,402 | +1492.5% | 0.00% | – |
| Q1 2021 | $2,000 | -77.8% | 402 | -73.4% | 0.00% | – |
| Q4 2020 | $9,000 | +125.0% | 1,514 | +153.2% | 0.00% | – |
| Q3 2020 | $4,000 | -20.0% | 598 | +2.0% | 0.00% | – |
| Q2 2020 | $5,000 | +400.0% | 586 | +44.7% | 0.00% | – |
| Q1 2020 | $1,000 | – | 405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 420,179 | $1,941,000 | 0.26% |
| Strategic Wealth Investment Group, LLC | 23,028 | $108,000 | 0.03% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 38,135 | $176,000 | 0.03% |
| Gladstone Institutional Advisory LLC | 12,170 | $56 | 0.01% |
| Compagnie Lombard Odier SCmA | 35,000 | $162,000 | 0.00% |
| Belvedere Trading LLC | 25,800 | $107,000 | 0.00% |
| Allworth Financial LP | 6,029 | $28,000 | 0.00% |
| VANGUARD GROUP INC | 408,638 | $1,888,000 | 0.00% |
| ALBION FINANCIAL GROUP /UT | 67 | $0 | 0.00% |
| EATON VANCE MANAGEMENT | 476 | $2,000 | 0.00% |